Courses by Topic

• Anatomic Pathology
• Clinical Pathology
• Practice Management
• Special Topics
• SAM Courses

---

Courses by Day

• Sunday
• Monday
• Tuesday
• Wednesday

---

Faculty Index

• A - G
• H - P
• Q - Z

Home | Education | Courses by Day – Tuesday | TP101  Breakfast Transformation Program – Breast Predictive Factors: ASCO-CAP Guideline for ER /PgR Testing: Elements and Implementation Strategies

TP101  Breakfast Transformation Program – Breast Predictive Factors: ASCO-CAP Guideline for ER /PgR Testing: Elements and Implementation Strategies

6:30–7:45 am
CME/CE Not Applicable

Estrogen receptor (ER) and progesterone receptor (PgR) testing provides information that guides clinicians in determining which patients should receive effective and well-tolerated hormonal treatments for breast cancer. The testing has been reported to have a high false-negative rate, which denies many patients this beneficial treatment. This short session will provide an overview of the elements of the guideline released earlier this year, that prevent these false-negative ER and PgR tests. Expert faculty will lead an interactive discussion on how to effectively implement the guideline in your practice and address related issues such as specimen handling, fixation, and processing variables. This session targets pathologists who are doing ER and PgR testing in their practice.

You will learn to:

• Explain the elements of the ASCO-CAP ER/PgR testing guideline and its implications for your pathology practice
• Identify recommended strategies for implementing the guidelines and its elements
• Compare and contrast the ER/PgR testing guideline with the ASCO-CAP HER2 guideline

No CME credit will be given for this course.

Faculty
M. Elizabeth Hammond, MD, FCAP
David G. Hicks, MD, FCAP